NAS
IMNM icon

Nykredit A/S’s Immunome IMNM Stock Holding History

Nykredit A/S’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9K Buy
+608
New +$13K ﹤0.01% 1838

Other funds holding IMNM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nykredit A/S's IMNM Position: Q2 2026 in Review

Nykredit A/S opened a new position in Immunome (IMNM) in Q2 2026: 608 shares worth $12.9K. The stake represents ﹤0.01% of the portfolio and ranks #1838 among its holdings.

125 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Nykredit A/S held 608 shares of Immunome worth $12.9K as of Q2 2026.
  • Immunome was a new Nykredit A/S position in Q2 2026.
  • Immunome made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1838 holding.
  • 125 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.